A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Professor Kwang-Hyun Cho's research team of the Department of Bio and Brain Engineering at KAIST has captured the critical ...

"We have discovered a molecular switch that can revert the fate of cancer cells," said biologist Kwang-Hyun Cho.

Scientists have found a molecular switch that reverses cancer cells in the body back to their normal, healthy state.

Professor Kwang-Hyun Cho's research team has recently been highlighted for their work on developing an original technology ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

PET scans use fluorodeoxyglucose (FDG), a radioactive form of glucose, to show how aggressively tumours consume glucose ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...